Position in CSTL
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$2,231,814
-$903,641 QoQ
Shares Held
90,909
+12.8% QoQ
Ownership
0.300%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in CSTL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026FRANKLIN RESOURCES INC holds $6,465,563,303 across 28 Diagnostics & Research names. CSTL ranks #23 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
6,813,031 | $3,348,809,122 | |
| 2 | DHR |
Danaher Corp /De/
|
4,566,512 | $865,810,670 | |
| 3 | NTRA |
Natera, Inc.
|
2,485,325 | $497,040,143 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
662,633 | $372,326,849 | |
| 5 | GH |
Guardant Health, Inc.
|
3,448,193 | $318,509,585 | |
| 6 | MTD |
Mettler Toledo International Inc/
|
195,467 | $246,522,977 | |
| 7 | WAT |
Waters Corp /De/
|
709,538 | $211,300,411 | |
| 8 | A |
Agilent Technologies, Inc.
|
907,425 | $103,428,297 |
All Filings in CSTL
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,231,814 | 90,909 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $3,135,455 | 80,603 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $2,272,149 | 99,787 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,026,622 | 99,247 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $1,983,700 | 99,086 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,962,424 | 73,637 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $1,978,773 | 69,382 | Shares | Defined | 2024-11-27 | |
| 2024-06-30 | $806,315 | 37,038 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $786,324 | 35,500 | Shares | Defined | 2024-05-13 | |
| No filing history on record for this holder in this stock. | ||||||